Application 220092
- Type
- NDA
- Sponsor
- JANSSEN PRODS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREZCOBIX PED | COBICISTAT; DARUNAVIR ETHANOLATE | TABLET, FOR SUSPENSION;ORAL | 90MG;EQ 600MG BASE | Yes | Yes |
| 002 | PREZCOBIX | DARUNAVIR AND COBICISTAT | TABLET, FOR SUSPENSION;ORAL | 675MG/150MG | No | No |
| 003 | PREZCOBIX | DARUNAVIR AND COBICISTAT | TABLET, FOR SUSPENSION;ORAL | 600MG/90MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N220092-001 | PREZCOBIX PED | COBICISTAT; DARUNAVIR ETHANOLATE | 90MG;EQ 600MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2026-02-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N220092-001 | PREZCOBIX PED | 90MG;EQ 600MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2026-02-27 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N220092-001 | PREZCOBIX PED | 90MG;EQ 600MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2026-02-27 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N220092-001 | PREZCOBIX PED | 90MG;EQ 600MG BASE | TABLET, FOR SUSPENSION / ORAL | RLD, RS | 2026-02-27 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PREZCOBIX | DARUNAVIR ETHANOLATE AND COBICISTAT | Janssen Products, LP | 9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f | 2026-02-01 | Warnings, Adverse reactions | 220092 NDA220092 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85220 | ORIG | 2026-03-03 |